Analysis of Stevens-Johnson syndrome and toxic epidermal necrolysis in Japan from 2000 to 2006

Allergology International

Volumn 56, Issue 4, 2007, Pages 419-425

  Yamane, Yumiko ^a   Aihara, Michiko ^a   Ikezawa, Zenro ^a  

^a YOKOHAMA CITY UNIVERSITY   (Japan)

Author keywords

Cause; Mortality; Stevens Johnson syndrome; Toxic epidermal necrolysis; Treatment

Indexed keywords

ALLOPURINOL; ANTIBIOTIC AGENT; ANTICONVULSIVE AGENT; ANTITUSSIVE AGENT; CARBAMAZEPINE; CARBOXYLIC ACID; CEPHALOSPORIN; CEPHEM; CONTRAST MEDIUM; CORTICOSTEROID; COTRIMOXAZOLE; IMMUNOGLOBULIN; MEXILETINE; NONSTEROID ANTIINFLAMMATORY AGENT; PENICILLIN G; SERRATIOPEPTIDASE; TETRACYCLINE; VANCOMYCIN;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG MEGADOSE; FEMALE; HEPATITIS; HUMAN; IMMUNOTHERAPY; JAPAN; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MONOTHERAPY; MORTALITY; PLASMAPHERESIS; PRIORITY JOURNAL; RESPIRATORY TRACT DISEASE; RETROSPECTIVE STUDY; RISK FACTOR; SEPSIS; SEX DIFFERENCE; STEROID THERAPY; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 37349123939     PISSN: 13238930     EISSN: 14401592     Source Type: Journal    
DOI: 10.2332/allergolint.O-07-483     Document Type: Article

References (28)

1. Stevens AM, Johnson FC. A new eruptive fever associated with stomatitis and opthalmia. Am. J. Dis. Child. 1922;24: 526-533.
2. Lyell A. Toxic epidermal necrolysis: an eruption resembling scalding of the skin. Br. J. Dermatol. 1956;68:355-361.
3. Bastuji-Garin S, Rzany B, Stern RS, Shear NH, Naldi L, Roujeau JC. Clinical classification of cases of toxic epidermal necrolysis, Stevens-Johnson syndrome, and erythema multiforme. Arch. Dermatol. 1993;129:92-96.
4. Schopf E, Stuhmer A, Rzany B, Victor N, Zentgraf R, Kapp JF. Toxic epidermal necrolysis and Stevens-Johnson syndrome. An epidemiologic study from West Germany. Arch. Dermatol. 1991;127:839-842.
5. Roujeau JC. The spectrum of Stevens-Johnson syndrome and toxic epidermal necrolysis: a clinical classification. J. Invest. Dermatol. 1994;102:28S-30S.
6. Roujeau JC. Stevens-Johnson syndrome and toxic epidermal necrolysis are severity variants of the same disease which differs from erythema multiforme. J. Dermatol. 1997;24:726-729.
7. Paul C, Wolkenstein P, Adle H et al. Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis. Br. J. Dermatol. 1996;134:710-714.
8. Caproni M, Torchia D, Schincaglia E et al. Expression of cytokines and chemokine receptors in the cutaneous lesions of erythema multiforme and Stevens-Johnson syndrome/toxic epidermal necrolysis. Br. J. Dermatol. 2006; 155:722-728.
9. Abe R, Shimizu T, Shibaki A, Nakamura H, Watanabe H, Shimizu H. Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand. Am. J. Pathol. 2003;162:1515-1520.
10. Viard I, Wehrli P, Bullani R et al. Inhibition of toxic epidermal necrolysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998;282:490-493.
11. Garcia-Doval I, LeCleach L, Bocquet H, Otero XL, Roujeau JC. Toxic epidermal necrolysis and Stevens-Johnson syndrome: does early withdrawal of causative drugs decrease the risk of death? Arch. Dermatol. 2000;136:323-327.
12. Mockenhaupt M, Schopf E. Epidemiology of drug-induced severe skin reactions. Semin. Cutan. Med. Surg. 1996;15:236-243.
13. Ghislain PD, Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson syndrome, toxic epidermal necrolysis and hypersensitivity syndrome. Dermatol. Online J. 2002;8:5.
14. French LE, Trent JT, Kerdel FA. Use of intravenous immunoglobulin in toxic epidermal necrolysis and Stevens-Johnson syndrome: our current understanding. Int. Immunopharmacol. 2006;6:543-549.
15. Prins C, Kerdel FA, Padilla RS et al. TEN-IVIG Study Group. Treatment of toxic epidermal necrolysis with high-dose intravenous immunoglobulins: multicenter retrospective analysis of 48 consecutive cases. Arch. Dermatol. 2003;139:26-32.
16. Kim KJ, Lee DP, Suh HS et al. Toxic epidermal necrolysis: analysis of clinical course and SCORTEN-based comparison of mortality rate and treatment modalities in Korean patients. Acta Derm. Venereol. 2005;85:497- 502.
17. Bamichas G, Natse T, Christidou F et al. Plasma exchange in patients with toxic epidermal necrolysis. Ther. Apher. 2002;6:225-228.
18. Egan CA, Grant WJ, Morris SE, Saffle JR, Zone JJ. Plasmapheresis as an adjunct treatment in toxic epidermal necrolysis. J. Am. Acad. Dermatol. 1999;40:458-461.
19. Kamanabroo D, Schmitz-Landgraf W, Czarnetzki BM. Plasmapheresis in severe drug-induced toxic epidermal necrolysis. Arch. Dermatol. 1985;121:1548-1549.
20. Letko E, Papaliodis DN, Papaliodis GN, Daoud YJ, Ahmed AR, Foster CS. Stevens-Johnson syndrome and toxic epidermal necrolysis: a review of the literature. Ann. Allergy Asthma Immunol. 2005;94:419-436; quiz 436-438, 456.
21. Aihara M, Ikezawa Z. Clinical study of deceased cases of Toxic epidermal necrolysis (TEN) in Japan; Comparative study with surviving cases of TEN and with deceased cases of Stevens-Johnson syndrome. Jpn. J. Dermatol. 1999;109:1581-1590.
22. Kim PS, Goldfarb IW, Gaisford JC et al. Stevens Johnson syndrome and toxic epidermal necrolysis: A pathophysiologic review with recommendations for a treatment protocol. J. Burn. Care Rehabil. 1983;4:91-100.
23. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved burn center survival of patients with toxic epidermal necrolysis managed without corticosteroids. Ann. Surg. 1986;204:503-512.
24. Murphy JT, Purdue GF, Hunt JL. Toxic epidermal necrolysis. J. Burn. Care Rehabil. 1997;18:417-420.
25. Tripathi A, Ditto AM, Grammer LC et al. Corticosteroid therapy in an additional 13 cases of Stevens-Johnson syndrome: a total series of 67 cases. Allergy Asthma Proc. 2000;21:101-105.
26. Moncada B, Delgado C, Quevedo ME, Lorincz AL. Abnormal T-cell response in toxic epidermal necrolysis. Arch. Dermatol. 1994;130:116-117.
27. Parsons JM. Management of toxic epidermal necrolysis. Cutis. 1985;36:305-307, 310-311.
28. Sherertz EF, Jegasothy BV, Lazarus GS. Phenytoin hypersensitivity reaction presenting with toxic epidermal necrolysis and severe hepatitis. Report of a patient treated with corticosteroid "pulse therapy". J. Am. Acad. Dermatol. 1985;12:178-181.